(Q34660084)

3 August 2017

1 reference

title

Human erythrovirus B19 and blood transfusion - an update (English)

1 reference

3 August 2017

Parsyan A

1

1 reference

PubMed ID

17680952

3 August 2017

Candotti D

series ordinal

2

1 reference

3 August 2017

1 August 2007

1 reference

3 August 2017

1 reference

3 August 2017

17

1 reference

3 August 2017

4

1 reference

3 August 2017

263-278

1 reference

Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

The transfusion-associated transmission of parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Risk of viral transmission via bone marrow progenitor cells versus umbilical cord blood hematopoietic stem cells in bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Parvovirus B19 transmission by heat-treated clotting factor concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Inactivation of parvovirus B19 during pasteurization of human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Different susceptibility of B19 virus and mice minute virus to low pH treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Identification and characterization of persistent human erythrovirus infection in blood donor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Parvovirus-like particles in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

High-sensitivity PCR detection of parvovirus B19 in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Occurrence and clinical role of active parvovirus B19 infection in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

21 January 2018

Human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Parvovirus B19 transmitted by bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

A new parvovirus genotype persistent in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

The structure of human parvovirus B19

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Broad-spectrum virus reduction in red cell concentrates using INACTINE PEN110 chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Persistent B19 infection in immunocompetent individuals: implications for transfusion safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Detection of parvovirus B19 IgG: choice of antigens and serological tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Effect of gamma irradiation on human cortical bone transplants contaminated with enveloped and non-enveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Eliminating parvovirus B19 from blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Genetic diversity within human erythroviruses: identification of three genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Prevalence of Parvovirus B19 in Liver Tissue: No Association with Fulminant Hepatitis or Hepatitis‐Associated Aplastic Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Parvovirus B19 transmission by a high-purity factor VIII concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Removal of small non-enveloped viruses by nanofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Heat sensitivity of human parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2007.00765.X

10.1111/J.1365-3148.2007.00765.X

21 January 2018

Identifiers

DOI

1 reference

release_scmoannok5bqbcomoaz46ulwfm

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/scmoannok5bqbcomoaz46ulwfm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17680952

1 reference

PubMed ID

17680952